The inflection to profitability is a major milestone for SYRA; monitor Q2 and Q3 for consistent positive earnings to confirm sustainability. The strong cash position supports ongoing operations without near-term dilution risk.
Price Chart
Executive Summary
Syra Health reported its first profitable quarter in Q1 2026, with net income of $241K compared to a net loss of $472K in Q1 2025. Revenue grew 22% YoY to $2.3M, gross margin expanded 11 points to 42.7%, and operating cash flow turned strongly positive. The company remains on track for full-year 2026 profitability.
Key Financial Metrics
Key Facts
- First profitable quarter in company history with net income of $240,979
- Revenue up 22% YoY to $2.3M driven by population health solutions (+46% YoY)
- Gross margin expanded 11 percentage points to 42.7%
- EPS improved to $0.02 from ($0.04) in Q1 2025
- Operating cash flow of $1.36M vs $158K in prior year
- Cash balance grew to $2.9M with no long-term debt
- Outlook maintains full-year 2026 profitability target despite quarterly variability
Financial Impact
Revenue +22% YoY to $2.27M, net income swing of +$713K vs prior year loss, gross margin +11pp
Risk Factors
- Small micro-cap with low liquidity and OTC listing
- Quarterly revenue variability due to milestone-based government contracts
- Dependence on government and healthcare contract renewals
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-021629 |
| Document: form8-k.htm | 0001493152-26-021629 |
| Document: 0001493152-26-021629-index-headers.html | 0001493152-26-021629 |
| Document: 0001493152-26-021629-index.html | 0001493152-26-021629 |
| Document: 0001493152-26-021629.txt | 0001493152-26-021629 |
| 8-K Data (Synthetic) | 0001493152-26-021629 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | EFFECT | $0.8500 $0.8300 | ▼ −2.35% | ▼ −1.20% | $0.8800 (+3.53%) |
Sep 14, 2026 6w ago | S-1 | $0.9400 $0.9600 | ▲ +2.13% | ▲ +1.31% | $0.8800 (−6.38%) |
Aug 11, 2026 11w ago | 8-K | $0.6650 $0.7800 | ▲ +17.29% | ▲ +17.70% | $0.8800 (+32.33%) |
Jun 1, 2026 21w ago | DEFA14A | $0.5100 $0.4900 | ▼ −3.92% | ▼ −0.96% | $0.8800 (+72.55%) |
May 7, 2026 24w ago | 8-K | $0.5000 $0.4390 | ▼ −12.20% | ▼ −13.70% | $0.8800 (+76.00%) |
Apr 24, 2026 26w ago | 10-K/A | $0.4180 $0.4100 | ▼ −1.91% | ▼ −2.31% | $0.8800 (+110.53%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers